Outcomes from Sjögren’s-associated lung disease worse in men
Primary Sjögren’s disease-associated interstitial lung disease tends to lead to worse outcomes in men, a study shows.| Sjogren's Disease News
Rise Therapeutics plans to launch a Phase 1 clinical trial testing R-2487, its experimental oral therapy for autoimmune diseases, in people with Sjögren’s disease. R-2487, which leverages bacterial proteins to suppress the abnormal immune responses in autoimmune diseases like Sjögren’s, “is disease-modifying, focusing on long-term immune correction rather than short-term symptom relief,” Christian Furlan Freguia, […] The post Rise’s R-2487 moves toward clinical testing as Sjögr...| Sjogren's Disease News – The Web's Daily Resource for Sjogren's Disease News
Primary Sjögren’s disease-associated interstitial lung disease tends to lead to worse outcomes in men, a study shows.| Sjogren's Disease News
Immune B-cells that contain the receptor protein CD226 may play a role in the development and clinical manifestations of primary Sjögren’s disease, making CD226 a possible target for future treatments, a study reports. Data indicated that people with Sjögren’s had proportionally more CD226-positive B-cells in their bloodstream than their healthy counterparts. The prevalence of these […] The post B-cells containing CD226 may be Sjögren’s biomarker, therapy target appeared first on S...| Sjogren's Disease News – The Web's Daily Resource for Sjogren's Disease News
A traditional Chinese medicine formulation called Qihuang Jianpi ZiShen Granule (QJZG) may help to alleviate Sjögren’s disease by reducing inflammatory molecules and associated tissue damage, according to computer simulations and tests in a cell model of the disease. “This study provides evidence supporting the use of Chinese medicine in treating [Sjögren’s disease],” researchers wrote. “However, […] The post Traditional Chinese medicine QJZG may help ease Sjögren’s disease a...| Sjogren's Disease News – The Web's Daily Resource for Sjogren's Disease News
The new name, Sjögren’s disease, is meant to better reflect the condition's nature and to provide clarity in clinical and research settings.| Sjogren's Disease News
Telitacicept safely and effectively eased disease activity in adults with primary Sjögren’s disease, according to data from a now-complete Phase 3 clinical trial conducted in China. Because the trial met its primary goal, developer Remegen plans to ask China’s regulator, the Center for Drug Evaluation of the National Medical Products Administration, to approve the drug, according […] The post Telitacicept shows promise for primary Sjögren’s in Phase 3 trial appeared first on Sjogre...| Sjogren's Disease News – The Web's Daily Resource for Sjogren's Disease News
Novartis' therapy candidate ianalumab safely and effectively eased disease activity for adults with active Sjögren's in two clinical trials.| Sjogren's Disease News
Levels of the receptor protein Mer tyrosine kinase (MerTK) in small salivary glands may be a useful marker for tracking disease activity and estimating tissue damage in Sjögren’s disease, a study reports. Researchers found that elevated MerTK, which plays a role in immune inflammation, was significantly associated with more disease activity and tissue damage. They […] The post MerTK protein in salivary glands could help track Sjögren’s activity appeared first on Sjogren's Disease News.| Sjogren's Disease News – The Web's Daily Resource for Sjogren's Disease News
Prompt treatment for Sjögren’s was found to improve recovery, and reduce the risk of recurrence, in patients who develop ischemic stroke.| Sjogren's Disease News
The Sjögren’s Foundation is asking people to make a pledge to take action for World Sjögren’s Day on July 23 to help support the foundation’s research and education programs. Longtime Sjögren’s Foundation supporter Debby Vivari will donate $2 for the first 5,000 pledges and anyone can make a pledge to honor themselves, others with Sjögren’s, […] The post Sjögren’s Foundation encourages ‘action’ on World Sjögren’s Day appeared first on Sjogren's Disease News.| Sjogren's Disease News – The Web's Daily Resource for Sjogren's Disease News
Andrea Lobo is a science writer for Sjogren's Syndrome News with a PhD in cell biology/neurosciences. She covers the latest news and information on a variety of Sjogren's topics.| Sjogren's Syndrome News
Lindsey Shapiro is a science writer for Sjogren's Syndrome News with a PhD in neuroscience. She covers the latest news and information on a variety of Sjogren's syndrome topics.| Sjogren's Syndrome News
Marisa Wexler is a senior science writer for Sjogren's Syndrome News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of Sjogren's syndrome topics.| Sjogren's Syndrome News
Category archive page for News.| Sjogren's Disease News
Margarida Maia is a science writer for Sjogren's Syndrome News with a PhD in biomedical sciences. She covers the latest news and information on a variety of Sjogren's syndrome topics.| Sjogren's Syndrome News
